Ligachem Bioscience founder Kim Yong-ju has launched The Iro Partners, a new VC firm with 3 billion won capital, to actively invest in and nurture South Korea's next wave of biotech startups, following his successful track record in drug development and technology licensing.
#YonhapInfomax #LigachemBioscience #KimYongJu #VentureCapital #BiotechStartups #TechnologyLicensing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104901